All News
Filter News
Found 45 articles
-
Release of Initial Attana Virus Analytics-AVA Testing Protocols
6/30/2020
Attana has today released the initial technical protocols for AVA Antibody Testing and will make these available to all existing Attana customers.
-
Clinical Catch-Up: June 22-26
6/29/2020
It was a busy week for clinical trial updates. Here’s a look. -
Linnaeus Therapeutics Announces Clinical Trial Collaboration Agreement with Merck to Evaluate LNS8801 in Combination with KEYTRUDA® in Patients with Advanced Cancer
6/23/2020
Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that it has entered into a clinical collaboration agreement with Merck to evaluate the combination of its lead investigational product candidate LNS8801
-
Linnaeus Therapeutics Granted U.S. FDA Fast Track Designation for LNS8801 for the Treatment of Patients with Metastatic or Unresectable Melanoma Who Have Progressed on Anti-PD-1/L1 Therapy
6/18/2020
Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small-molecule oncology therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for LNS8801 for the treatment of patients with metastatic or unresectable melanoma
-
Linnaeus Therapeutics Scientific Cofounders Publish Preclinical Pancreatic Cancer Data in Cellular and Molecular Gastroenterology and Hepatology
6/10/2020
Linnaeus Therapeutics, Inc. (Linnaeus), a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics, today announced that its scientific cofounders, Christopher Natale , PhD, Vice President of Research at Linnaeus and Todd Ridky , MD, PhD
-
Wisdom Health Genetics Rolls Out Enhanced Dog DNA Tests
5/12/2020
Designed for new pet parents, Wisdom Panel™ Essential dog DNA test provides breed, ancestry, trait and health insights; Wisdom Panel™ Premium dog DNA test includes the most comprehensive health screening of its kind
-
New Report on Addressing the Loneliness Crisis Through the Power of Pets
2/20/2020
HABRI and Mars Petcare partnership reveals roadmap for future research, best practices and solutions to increase impact of companion animals on social isolation and loneliness
-
First-of-its-kind study reveals genetic traits determining coat colors and physical appearance in over 200 dog breeds
11/5/2019
Wisdom Health - the world's leader in pet genetics and researchers at Purdue University announced the most comprehensive study of dog coat color and physical trait genes ever conducted is published in PLOS ONE.
-
Clinical Catch-Up: October 28-Nov 1
11/4/2019
Even clinical trial announcements don’t slow down for Halloween. It was a typically busy week. Here’s a look. -
Linnaeus Therapeutics Announces First Patient Dosed in Its Phase 1/2 Clinical Trial of LNS8801 in Patients with Advanced Cancer
10/29/2019
Company Commences First-in-Human Study at Multiple Academic Sites in United States
-
New AI-driven diagnostic tool can predict chronic kidney disease in cats two years before onset
10/1/2019
RenalTech™ predictive diagnostic tool is a first for veterinarians, signaling new potential for personalized health care for pets
-
Linnaeus Therapeutics Announces FDA Clearance of Investigational New Drug Application for LNS8801
9/24/2019
Company Set to Commence Phase 1/2 Clinical Trial in Patients with Advanced Cancer
-
Linnaeus Therapeutics Closes $12 Million Series B Financing
9/17/2019
Linnaeus Therapeutics, Inc. announced that it has closed a $12 million series B financing.
-
Linnaeus Therapeutics Scientific Cofounder Presents Preclinical Pancreatic Cancer Data at AACR Pancreas Cancer Meeting
9/10/2019
American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care, which took place September 6-9, 2019, at the Westin Copley Place in Boston, Massachusetts.
-
Erica Coletta Joins Mars, Incorporated to Lead Global Petcare P&O
5/7/2019
Mars Petcare announced that Erica Coletta joins the global leadership team of the Petcare business to lead the People & Organization function.
-
First-Of-Its-Kind Coalition Launches To Drive Pet Care Innovation
4/3/2019
Mars Petcare, the global leader in pet health and nutrition, announced the launch of Kinship, a first-of-its-kind coalition dedicated to creating the future of pet care.
-
Paulo de Castro Joins Mars, Incorporated as Chief Financial Officer of Mars Petcare
4/2/2019
Mars Petcare announced today that Paulo de Castro will join their global management team as the leader of the finance function.
-
Mars Petcare, Michelson Found Animals Foundation, and R/GA Announce Companies Selected to Join Second Leap Venture Studio
3/4/2019
Early and growth stage companies transforming pet communities, cat food, sustainable nutrition, pharmaceutical alternatives, and AI in preventative care join the second round of the program
-
New Diverse Field Crops Cluster Goal to Increase Cropping Options for Farmers
1/15/2019
The Diverse Field Crops Cluster (DFCC) will benefit farmers, and ultimately, all of Canada, by increasing the variety of crops that Canadian farmers grow.
-
New Research From The University of Liverpool and WALTHAM Reveals Overweight Dogs May Live Shorter Lives
1/3/2019
Study of over 50,000 dogs across 12 breeds shows link between a dog's weight and expected lifespan